| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
ABCA12
|
ATP-binding cassette, sub-family A (ABC1), member 12
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACIN1
|
apoptotic chromatin condensation inducer 1
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACT
|
actin-like protein (ACT) gene
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AIMP1
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT1S1
|
AKT1 substrate 1 (proline-rich)
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALYREF
|
Aly/REF export factor
|
|
ANGPT1
|
angiopoietin 1
|
|
ANXA2
|
annexin A2
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
APPL1
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1
|
|
AR
|
androgen receptor
|
|
AREG
|
amphiregulin
|
|
ARFIP2
|
ADP-ribosylation factor interacting protein 2
|
|
ARHGEF1
|
Rho guanine nucleotide exchange factor (GEF) 1
|
|
ARRB1
|
arrestin, beta 1
|
|
ARRB2
|
arrestin, beta 2
|
|
ASAH1
|
N-acylsphingosine amidohydrolase (acid ceramidase) 1
|
|
ASAH2
|
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AVP
|
arginine vasopressin
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L2
|
BCL2-like 2
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BGN
|
biglycan
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRMS1
|
breast cancer metastasis suppressor 1
|
|
BTBD10
|
BTB (POZ) domain containing 10
|
|
BTG2
|
BTG family, member 2
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
|
C1QC
|
complement component 1, q subcomponent, C chain
|
|
C1QTNF6
|
C1q and tumor necrosis factor related protein 6
|
|
C3
|
complement component 3
|
|
C5
|
complement component 5
|
|
C6
|
complement component 6
|
|
C7
|
complement component 7
|
|
C8B
|
complement component 8, beta polypeptide
|
|
C9
|
complement component 9
|
|
CABYR
|
calcium binding tyrosine-(Y)-phosphorylation regulated
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CAMKK2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase
|
|
CC2D1A
|
coiled-coil and C2 domain containing 1A
|
|
CCDC88A
|
coiled-coil domain containing 88A
|
|
CCK
|
cholecystokinin
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCNG1
|
cyclin G1
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD274
|
CD274 molecule
|
|
CD28
|
CD28 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD82
|
CD82 molecule
|
|
CDC37
|
cell division cycle 37
|
|
CDC42
|
cell division cycle 42
|
|
CDCP1
|
CUB domain containing protein 1
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHGA
|
chromogranin A
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CKMT1A
|
creatine kinase, mitochondrial 1A
|
|
CLCN3
|
chloride channel, voltage-sensitive 3
|
|
CLK2
|
CDC-like kinase 2
|
|
CLU
|
clusterin
|
|
CNKSR1
|
connector enhancer of kinase suppressor of Ras 1
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CNTN1
|
contactin 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CSNK1E
|
casein kinase 1, epsilon
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTTN
|
cortactin
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
CYTH2
|
cytohesin 2
|
|
DAB1
|
Dab, reelin signal transducer, homolog 1 (Drosophila)
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DCBLD2
|
discoidin, CUB and LCCL domain containing 2
|
|
DCK
|
deoxycytidine kinase
|
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1
|
|
DDIT4
|
DNA-damage-inducible transcript 4
|
|
DDIT4L
|
DNA-damage-inducible transcript 4-like
|
|
DEC1
|
deleted in esophageal cancer 1
|
|
DEFB4A
|
defensin, beta 4A
|
|
DEPTOR
|
DEP domain containing MTOR-interacting protein
|
|
DGKD
|
diacylglycerol kinase, delta 130kDa
|
|
DIRAS3
|
DIRAS family, GTP-binding RAS-like 3
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOCK1
|
dedicator of cytokinesis 1
|
|
DOCK2
|
dedicator of cytokinesis 2
|
|
DRD2
|
dopamine receptor D2
|
|
DUOX1
|
dual oxidase 1
|
|
DUOX2
|
dual oxidase 2
|
|
DYNAP
|
dynactin associated protein
|
|
DYNC1I1
|
dynein, cytoplasmic 1, intermediate chain 1
|
|
E2F1
|
E2F transcription factor 1
|
|
EDN1
|
endothelin 1
|
|
EEA1
|
early endosome antigen 1
|
|
EFNB2
|
ephrin-B2
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ENTPD5
|
ectonucleoside triphosphate diphosphohydrolase 5
|
|
EP300
|
E1A binding protein p300
|
|
EPHA2
|
EPH receptor A2
|
|
EPHB2
|
EPH receptor B2
|
|
EPHB4
|
EPH receptor B4
|
|
EPO
|
erythropoietin
|
|
EPS8
|
epidermal growth factor receptor pathway substrate 8
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB2IP
|
erbb2 interacting protein
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAIM
|
Fas apoptotic inhibitory molecule
|
|
FAM107A
|
family with sequence similarity 107, member A
|
|
FAM9C
|
family with sequence similarity 9, member C
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FBXO31
|
F-box protein 31
|
|
FBXO32
|
F-box protein 32
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FHIT
|
fragile histidine triad
|
|
FHL1
|
four and a half LIM domains 1
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLNA
|
filamin A, alpha
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FN1
|
fibronectin 1
|
|
FOXM1
|
forkhead box M1
|
|
FOXN1
|
forkhead box N1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FOXO6
|
forkhead box O6
|
|
FOXP3
|
forkhead box P3
|
|
FPR2
|
formyl peptide receptor 2
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FXYD5
|
FXYD domain containing ion transport regulator 5
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA2
|
GATA binding protein 2
|
|
GCG
|
glucagon
|
|
GDF15
|
growth differentiation factor 15
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GIPC1
|
GIPC PDZ domain containing family, member 1
|
|
GLI1
|
GLI family zinc finger 1
|
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNB1
|
guanine nucleotide binding protein (G protein), beta polypeptide 1
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GNGT2
|
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GPBAR1
|
G protein-coupled bile acid receptor 1
|
|
GPC3
|
glypican 3
|
|
GPX1
|
glutathione peroxidase 1
|
|
GRB10
|
growth factor receptor-bound protein 10
|
|
GRB14
|
growth factor receptor-bound protein 14
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRB7
|
growth factor receptor-bound protein 7
|
|
GRPR
|
gastrin-releasing peptide receptor
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTO1
|
glutathione S-transferase omega 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC4
|
histone deacetylase 4
|
|
HDGF
|
hepatoma-derived growth factor
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HK2
|
hexokinase 2
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HN1
|
hematological and neurological expressed 1
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HNRNPC
|
heterogeneous nuclear ribonucleoprotein C (C1/C2)
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HOXD10
|
homeobox D10
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB2
|
heat shock 27kDa protein 2
|
|
HSPB6
|
heat shock protein, alpha-crystallin-related, B6
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HTT
|
huntingtin
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICAM3
|
intercellular adhesion molecule 3
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
IL11
|
interleukin 11
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL17RA
|
interleukin 17 receptor A
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RAP
|
interleukin 1 receptor accessory protein
|
|
IL2
|
interleukin 2
|
|
IL22
|
interleukin 22
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL24
|
interleukin 24
|
|
IL25
|
interleukin 25
|
|
IL32
|
interleukin 32
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL7R
|
interleukin 7 receptor
|
|
ILF3
|
interleukin enhancer binding factor 3, 90kDa
|
|
ILK
|
integrin-linked kinase
|
|
INHBA
|
inhibin, beta A
|
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
IRX2
|
iroquois homeobox 2
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITGB5
|
integrin, beta 5
|
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
|
JAG1
|
jagged 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KCNH1
|
potassium channel, voltage gated eag related subfamily H, member 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCTD20
|
potassium channel tetramerization domain containing 20
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA1524
|
KIAA1524
|
|
KIF2A
|
kinesin heavy chain member 2A
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KITLG
|
KIT ligand
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF9
|
Kruppel-like factor 9
|
|
KLK1
|
kallikrein 1
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1
|
|
KNG1
|
kininogen 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT17
|
keratin 17, type I
|
|
KRT19
|
keratin 19, type I
|
|
LAT
|
linker for activation of T cells
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEPR
|
leptin receptor
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS3BP
|
lectin, galactoside-binding, soluble, 3 binding protein
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LMNA
|
lamin A/C
|
|
LMO1
|
LIM domain only 1 (rhombotin 1)
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
|
|
LTB4R2
|
leukotriene B4 receptor 2
|
|
LTF
|
lactotransferrin
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
LYRM1
|
LYR motif containing 1
|
|
LZTS2
|
leucine zipper, putative tumor suppressor 2
|
|
MACC1
|
metastasis associated in colon cancer 1
|
|
MADD
|
MAP-kinase activating death domain
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAP3K3
|
mitogen-activated protein kinase kinase kinase 3
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPKAP1
|
mitogen-activated protein kinase associated protein 1
|
|
MAPT
|
microtubule-associated protein tau
|
|
MC3R
|
melanocortin 3 receptor
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MED1
|
mediator complex subunit 1
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MID1
|
midline 1
|
|
MIEN1
|
migration and invasion enhancer 1
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR101-1
|
microRNA 101-1
|
|
MIR10B
|
microRNA 10b
|
|
MIR124-1
|
microRNA 124-1
|
|
MIR126
|
microRNA 126
|
|
MIR141
|
microRNA 141
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR146B
|
microRNA 146b
|
|
MIR155
|
microRNA 155
|
|
MIR15A
|
microRNA 15a
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR181C
|
microRNA 181c
|
|
MIR185
|
microRNA 185
|
|
MIR192
|
microRNA 192
|
|
MIR200B
|
microRNA 200b
|
|
MIR200C
|
microRNA 200c
|
|
MIR21
|
microRNA 21
|
|
MIR210
|
microRNA 210
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR224
|
microRNA 224
|
|
MIR26A1
|
microRNA 26a-1
|
|
MIR329-1
|
microRNA 329-1
|
|
MIR330
|
microRNA 330
|
|
MIR34A
|
microRNA 34a
|
|
MIR34B
|
microRNA 34b
|
|
MIR375
|
microRNA 375
|
|
MIR7-1
|
microRNA 7-1
|
|
MIR7-2
|
microRNA 7-2
|
|
MIR7-3
|
microRNA 7-3
|
|
MIR93
|
microRNA 93
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MSTN
|
myostatin
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC3
|
intestinal mucin-like
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUL1
|
mitochondrial E3 ubiquitin protein ligase 1
|
|
MXD1
|
MAX dimerization protein 1
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow
|
|
NBN
|
nibrin
|
|
NCF1C
|
neutrophil cytosolic factor 1C pseudogene
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NDRG2
|
NDRG family member 2
|
|
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
|
|
NEU4
|
sialidase 4
|
|
NFAT5
|
nuclear factor of activated T-cells 5, tonicity-responsive
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NNMT
|
nicotinamide N-methyltransferase
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOV
|
nephroblastoma overexpressed
|
|
NOX4
|
NADPH oxidase 4
|
|
NPPA
|
natriuretic peptide A
|
|
NPTX2
|
neuronal pentraxin II
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRF1
|
nuclear respiratory factor 1
|
|
NRG1
|
neuregulin 1
|
|
NRP1
|
neuropilin 1
|
|
NTN1
|
netrin 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTS
|
neurotensin
|
|
NUAK1
|
NUAK family, SNF1-like kinase, 1
|
|
NUDT1
|
nudix (nucleoside diphosphate linked moiety X)-type motif 1
|
|
ODAM
|
odontogenic, ameloblast asssociated
|
|
ODC1
|
ornithine decarboxylase 1
|
|
OGDHL
|
oxoglutarate dehydrogenase-like
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
ORAI3
|
ORAI calcium release-activated calcium modulator 3
|
|
OSBPL9
|
oxysterol binding protein-like 9
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
PA2G4
|
proliferation-associated 2G4, 38kDa
|
|
PACS2
|
phosphofurin acidic cluster sorting protein 2
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PALD1
|
phosphatase domain containing, paladin 1
|
|
PALLD
|
palladin, cytoskeletal associated protein
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PARVB
|
parvin, beta
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PCGF2
|
polycomb group ring finger 2
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFC
|
platelet derived growth factor C
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDK1
|
pyruvate dehydrogenase kinase, isozyme 1
|
|
PDK2
|
pyruvate dehydrogenase kinase, isozyme 2
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PDZK1IP1
|
PDZK1 interacting protein 1
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PER2
|
period circadian clock 2
|
|
PGR
|
progesterone receptor
|
|
PHB2
|
prohibitin 2
|
|
PHF20
|
PHD finger protein 20
|
|
PHLDA3
|
pleckstrin homology-like domain, family A, member 3
|
|
PHLPP1
|
PH domain and leucine rich repeat protein phosphatase 1
|
|
PHLPP2
|
PH domain and leucine rich repeat protein phosphatase 2
|
|
PI4K2A
|
phosphatidylinositol 4-kinase type 2 alpha
|
|
PI4KB
|
phosphatidylinositol 4-kinase, catalytic, beta
|
|
PID1
|
phosphotyrosine interaction domain containing 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIK3R2
|
phosphoinositide-3-kinase, regulatory subunit 2 (beta)
|
|
PIK3R6
|
phosphoinositide-3-kinase, regulatory subunit 6
|
|
PIKFYVE
|
phosphoinositide kinase, FYVE finger containing
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIM2
|
Pim-2 proto-oncogene, serine/threonine kinase
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKIB
|
protein kinase (cAMP-dependent, catalytic) inhibitor beta
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLD2
|
phospholipase D2
|
|
PLD3
|
phospholipase D family, member 3
|
|
PLEKHF2
|
pleckstrin homology domain containing, family F (with FYVE domain) member 2
|
|
PLEKHO1
|
pleckstrin homology domain containing, family O member 1
|
|
PLG
|
plasminogen
|
|
PLXNB1
|
plexin B1
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
PNKD
|
paroxysmal nonkinesigenic dyskinesia
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPM1G
|
protein phosphatase, Mg2+/Mn2+ dependent, 1G
|
|
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme
|
|
PPP1R16B
|
protein phosphatase 1, regulatory subunit 16B
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
|
PRKACG
|
protein kinase, cAMP-dependent, catalytic, gamma
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCH
|
protein kinase C, eta
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRKG2
|
protein kinase, cGMP-dependent, type II
|
|
PRMT1
|
protein arginine methyltransferase 1
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PRODH
|
proline dehydrogenase (oxidase) 1
|
|
PROK1
|
prokineticin 1
|
|
PROM1
|
prominin 1
|
|
PRPH
|
peripherin
|
|
PRR5
|
proline rich 5 (renal)
|
|
PSMD10
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 10
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTK6
|
protein tyrosine kinase 6
|
|
PTK7
|
protein tyrosine kinase 7 (inactive)
|
|
PTN
|
pleiotrophin
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRE
|
protein tyrosine phosphatase, receptor type, E
|
|
PTPRH
|
protein tyrosine phosphatase, receptor type, H
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PXN
|
paxillin
|
|
RAB38
|
RAB38, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RALA
|
v-ral simian leukemia viral oncogene homolog A (ras related)
|
|
RAP2A
|
RAP2A, member of RAS oncogene family
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RCAN1
|
regulator of calcineurin 1
|
|
REG1A
|
regenerating islet-derived 1 alpha
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RGCC
|
regulator of cell cycle
|
|
RGS13
|
regulator of G-protein signaling 13
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RHOC
|
ras homolog family member C
|
|
RHOU
|
ras homolog family member U
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RIOK1
|
RIO kinase 1
|
|
RIOK2
|
RIO kinase 2
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPS6KB2
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
RQCD1
|
RCD1 required for cell differentiation1 homolog (S. pombe)
|
|
RRM2B
|
ribonucleotide reductase M2 B (TP53 inducible)
|
|
RRN3
|
RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae)
|
|
RUNX3
|
runt-related transcription factor 3
|
|
S100A4
|
S100 calcium binding protein A4
|
|
SACK1B
|
scaffolding CK1 anchoring protein B
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCGB3A1
|
secretoglobin, family 3A, member 1
|
|
SCRIB
|
scribbled planar cell polarity protein
|
|
SDCBP
|
syndecan binding protein (syntenin)
|
|
SEMA3B
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SERTAD1
|
SERTA domain containing 1
|
|
SESN2
|
sestrin 2
|
|
SESN3
|
sestrin 3
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SGK3
|
serum/glucocorticoid regulated kinase family, member 3
|
|
SHARPIN
|
SHANK-associated RH domain interactor
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHH
|
sonic hedgehog
|
|
SIK2
|
salt-inducible kinase 2
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SIRT1
|
sirtuin 1
|
|
SIRT2
|
sirtuin 2
|
|
SKI
|
SKI proto-oncogene
|
|
SKP1
|
S-phase kinase-associated protein 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
|
SLC27A3
|
solute carrier family 27 (fatty acid transporter), member 3
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC38A1
|
solute carrier family 38, member 1
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMARCC1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1
|
|
SMARCD3
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SORBS2
|
sorbin and SH3 domain containing 2
|
|
SORT1
|
sortilin 1
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP7
|
Sp7 transcription factor
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPHK2
|
sphingosine kinase 2
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRR3
|
small proline-rich protein 3
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRPK1
|
SRSF protein kinase 1
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
|
ST13
|
suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)
|
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1
|
|
ST8SIA1
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STEAP4
|
STEAP family member 4
|
|
STK11
|
serine/threonine kinase 11
|
|
STK3
|
serine/threonine kinase 3
|
|
STK4
|
serine/threonine kinase 4
|
|
SYK
|
spleen tyrosine kinase
|
|
SYNM
|
synemin, intermediate filament protein
|
|
TAC1
|
tachykinin, precursor 1
|
|
TBC1D4
|
TBC1 domain family, member 4
|
|
TBK1
|
TANK-binding kinase 1
|
|
TCF3
|
transcription factor 3
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TCL1B
|
T-cell leukemia/lymphoma 1B
|
|
TDGF1
|
teratocarcinoma-derived growth factor 1
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFAP2C
|
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
THBS1
|
thrombospondin 1
|
|
THBS2
|
thrombospondin 2
|
|
THEM4
|
thioesterase superfamily member 4
|
|
THPO
|
thrombopoietin
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIGAR
|
TP53 induced glycolysis regulatory phosphatase
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TLR2
|
toll-like receptor 2
|
|
TMSB10
|
thymosin beta 10
|
|
TMSB4X
|
thymosin beta 4, X-linked
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TOB1
|
transducer of ERBB2, 1
|
|
TOLLIP
|
toll interacting protein
|
|
TOPBP1
|
topoisomerase (DNA) II binding protein 1
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TPD52
|
tumor protein D52
|
|
TPP1
|
tripeptidyl peptidase I
|
|
TRADD
|
TNFRSF1A-associated via death domain
|
|
TRAF4
|
TNF receptor-associated factor 4
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRAP1
|
TNF receptor-associated protein 1
|
|
TRIB3
|
tribbles pseudokinase 3
|
|
TRIM13
|
tripartite motif containing 13
|
|
TRIM27
|
tripartite motif containing 27
|
|
TRIM63
|
tripartite motif containing 63, E3 ubiquitin protein ligase
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSC22D3
|
TSC22 domain family, member 3
|
|
TTC3
|
tetratricopeptide repeat domain 3
|
|
TUSC2
|
tumor suppressor candidate 2
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
ULK1
|
unc-51 like autophagy activating kinase 1
|
|
USP22
|
ubiquitin specific peptidase 22
|
|
USP4
|
ubiquitin specific peptidase 4 (proto-oncogene)
|
|
USP46
|
ubiquitin specific peptidase 46
|
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCP
|
valosin containing protein
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VTN
|
vitronectin
|
|
WDFY2
|
WD repeat and FYVE domain containing 2
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
|
|
YWHAE
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
|
|
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
ZBTB7A
|
zinc finger and BTB domain containing 7A
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZMYM2
|
zinc finger, MYM-type 2
|
